Biomarker: F037-IgE Mussel

Overview

F037-IgE Mussel measures mussel-specific immunoglobulin E (IgE) antibodies in blood, typically directed against blue mussel (Mytilus edulis) allergen extracts. IgE is an antibody involved in immediate allergic reactions, and mussel allergens include proteins such as tropomyosin. A detectable result indicates sensitization to mussel but does not by itself confirm a clinical allergy or predict reaction severity. The test is clinically useful when interpreted with the patient’s exposure history and symptoms as part of an evaluation for suspected mollusk or shellfish allergy.

Clinical Use Cases

Supporting evaluation of suspected IgE-mediated mussel allergy after compatible symptoms following mussel exposure.
Identifying sensitization to mussel as part of a broader shellfish or mollusk allergy assessment.
Supporting differential evaluation when reactions may involve multiple shellfish species.
Complementing clinical history, skin-prick testing, and, when appropriate, a medically supervised oral food challenge.
Investigating possible cross-reactivity between mollusks and crustaceans, recognizing that current tests may not reliably predict clinical cross-reactivity.

Specimen Types

Venous blood serum.
Plasma may be accepted by some assay systems, but serum is the usual specimen for allergen-specific IgE measurement.

Measurement Methods

Quantitative allergen-specific IgE immunoassay using mussel extract bound to a solid phase.
Fluorescence enzyme immunoassay, such as an ImmunoCAP-based method.
Enzyme-linked immunosorbent assay in research settings.
Immunoblotting or other component-based methods in research settings, including investigation of mussel allergen proteins such as tropomyosin.

Test Preparation and Influencing Factors

Fasting is generally not required for a blood-based specific-IgE test.
Patients should report all medications and supplements to the ordering clinician.
Antihistamines can interfere with skin-prick testing, but they generally do not affect serum-specific IgE measurement. Medication changes should be made only when directed by a healthcare professional.
Results should be interpreted with the timing, amount, and preparation of mussel consumed and the patient’s symptoms.
A positive result indicates sensitization and does not independently establish clinical allergy or predict reaction severity.
Total IgE levels, atopic conditions, and sensitization to related shellfish allergens may complicate interpretation.
The allergen extract, assay platform, reporting units, and decision thresholds can vary between laboratories.
A supervised oral food challenge may be required when history and testing do not establish clinical relevance. It is the reference method for confirming food allergy but must be performed in an appropriately equipped clinical setting.